Skip to content
OpenCapital
Get started

Spruce Biosciences, Inc. SPRB Q3 2025 earnings

Reported November 10, 2025 · Before market open

Diluted EPS-$14.58Beat by $0.98
EPS estimate-$15.56

Next report

Aug 13, 2026 (in a month)
EPS estimate-$6.04

Versus estimates

Revenue

Q4 2024$697.0KMiss by $188.0K

Diluted EPS

Q1 2026-$8.94Miss by $1.62Q4 2025-$9.58Beat by $3.29
Q3 2025-$14.58Beat by $0.98
Q2 2025-$3.50Beat by $14.55Q1 2025-$24.06Miss by $5.26Q4 2024-$0.23Beat by $0.01

Ask the moment Spruce Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Spruce Biosciences, Inc. report Q3 2025 earnings?
Spruce Biosciences, Inc. (SPRB) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Spruce Biosciences, Inc. 's Q3 2025 revenue and EPS?
Spruce Biosciences, Inc. reported diluted EPS of $-14.58 for Q3 2025.
Did Spruce Biosciences, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-15.56 by $0.98.
How did Spruce Biosciences, Inc. 's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 7.7% from $-15.79.
Where can I find Spruce Biosciences, Inc. 's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-274216) and the 10-Q periodic report (0001193125-25-274234) directly on SEC EDGAR. The filing index links above go to sec.gov.